N-acetylglucosamine

N-acetylglucosamine has been studied in 4 papers since 2003: none in people yet, 1 in animals, 2 in cells, 1 review. The research so far is in animals and cells.

Intervention

4 papers study it20 more mention it1 findingUpdated

PubChemChEBI

None of its findings points the other way.

  • 2 independent labs in 1 country
  • Funder: National Heart, Lung, and Blood Institute
  • Animals1
  • Cells2

What did lifespan studies of N-acetylglucosamine find?

DrugAge

DrugAge records 1 result from 1 paper: 1 in C. elegans. Average lifespan is the mean or the median, as each paper reports it.

What did studies of N-acetylglucosamine find?

1

Studies of N-acetylglucosamine measured 1 outcome; the most studied are CD4+ T-cell proliferation (1 study).

CD4+ T-cell proliferation

no changein cells1

1 study
  1. N-acetylglucosamine has no effect on CD4+ T-cell proliferation in cells.

    “GlcN, but not GlcNAc, inhibits CD4+ T-cell proliferation”

    Cellsin primary and secondary mixed lymphocyte cultures

    Immunobiological effects of glucosamine in vitro

    Scandinavian journal of immunology

More on CD4+ T-cell proliferation

Funding

1 grant since 2020

National Heart, Lung, and Blood InstituteUS$222.8k

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 2Aug 2026: 0Sep 2026: 0Oct 2026: 04 papers in 12 months